The US Food and Drug Administration's Model-Informed Drug Development Meeting Program: From Pilot to Pathway

被引：5
|
作者：
Madabushi, Rajanikanth [1 ]
Benjamin, Jessica [1 ]
Zhu, Hao [1 ]
Zineh, Issam [1 ]
机构：
[1] US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol, Off Translat Sci, Silver Spring, MD 20993 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 116卷 / 02期
关键词：
D O I：
10.1002/cpt.3228
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：278 / 281
页数：4
相关论文
共 50 条
  • [1] The US Food and Drug Administration's Model-Informed Drug Development Paired Meeting Pilot Program: Early Experience and Impact
    Madabushi, Rajanikanth
    Benjamin, Jessica M.
    Grewal, Renmeet
    Pacanowski, Michael A.
    Strauss, David G.
    Wang, Yaning
    Zhu, Hao
    Zineh, Issam
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 74 - 78
  • [2] Industrial Perspective on the Benefits Realized from the FDA's Model-Informed Drug Development Paired Meeting Pilot Program
    Galluppi, Gerald R.
    Brar, Satjit
    Caro, Luzelena
    Chen, Yuan
    Frey, Nicolas
    Grimm, Hans Peter
    Rudd, Deanne Jackson
    Li, Chi-Chung
    Magee, Mindy
    Mukherjee, Arnab
    Nagao, Lee
    Purohit, Vivek S.
    Roy, Amit
    Salem, Ahmed Hamed
    Sinha, Vikram
    Suleiman, Ahmed A.
    Taskar, Kunal S.
    Upreti, Vijay V.
    Weber, Benjamin
    Cook, Jack
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1172 - 1175
  • [3] Proceedings of a Workshop: US Food and Drug Administration-International Society of Pharmacometrics Model-Informed Drug Development in Oncology
    Bruno, Rene
    Jin, Jin Y.
    Maxfield, Kimberly
    Milligan, Lauren
    Liu, Chao
    Wang, Yaning
    McKee, Amy E.
    Zineh, Issam
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 81 - 83
  • [4] Perspective on model-informed drug development
    Lesko, Lawrence J.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (10): : 1127 - 1129
  • [5] Reflections on Model-Informed Drug Development
    Lesko, Lawrence J.
    van der Graaf, Piet H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (02) : 267 - 270
  • [6] Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program
    Galluppi, Gerald R.
    Ahamadi, Malidi
    Bhattacharya, Souvik
    Budha, Nageshwar
    Gheyas, Ferdous
    Li, Chi-Chung
    Chen, Yuan
    Dosne, Anne-Gaelle
    Kristensen, Niels Rode
    Magee, Mindy
    Samtani, Mahesh N.
    Sinha, Vikram
    Taskar, Kunal
    Upreti, Vijay V.
    Yang, Jianning
    Cook, Jack
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (02) : 282 - 288
  • [7] The US Food and Drug Administration's Complex Innovative Trial Design Pilot Meeting Program: Progress to date
    Price, Dionne
    Scott, John
    CLINICAL TRIALS, 2021, 18 (06) : 706 - 710
  • [8] Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration
    Djuris, Jelena
    Cvijic, Sandra
    Djekic, Ljiljana
    PHARMACEUTICALS, 2024, 17 (02)
  • [9] Model-Informed Drug Development for Malaria Therapeutics
    Andrews, Kayla Ann
    Wesche, David
    McCarthy, James
    Mohrle, Jorg J.
    Tarning, Joel
    Phillips, Luann
    Kern, Steven
    Grasela, Thaddeus
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 567 - 582
  • [10] Model-Informed Drug Development (MIDD) for Antimicrobials
    Lin, Yu-Wei
    Cheung, S. Y. Amy
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (06)
12345